Merck & Co., Inc.
The Senior Scientist supports biomarker discovery and validation across the neuroscience portfolio by developing and applying mass spectrometry-based assays for preclinical drug development. This role focuses on novel target and translational biomarker discovery for neurodegenerative diseases within multidisciplinary drug discovery teams. The position involves exploring disease mechanisms, identifying biomarkers for clinical translation, and advancing new therapeutics.
Headquarters
Rahway, New Jersey, United States
Company Size
10001+ employees
Founded
1891
Merck is a global science company focused on improving health by following the science to tackle some of the world’s greatest health threats. The company concentrates its efforts on research and development to deliver medicines, vaccines, and health solutions that improve lives. By applying scientific discovery to real-world needs, Merck translates breakthroughs into accessible therapies and preventive measures worldwide. With a global footprint and a commitment to science-driven innovation, Merck aims to advance health outcomes and make a lasting impact on patients and communities.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Merck & Co., Inc..
9% above the average for this role
Director - Mass Spectrometry-based Biomarker Discovery - Neuroscience
Eli Lilly and Company
Senior Scientist, Mass Spectrometry
Insmed Incorporated
Postdoctoral Researcher-Schilling lab
Buck Institute
Post Doctoral Scholar
The Ohio State University
Scientist, R&D Proteomics
CellCarta
Associate Director, Proteomics
Inotiv